Chimeric Antigen Receptor–Engineered T Cell Therapy in Lymphoma

Paolo Strati, Sattva S. Neelapu

Research output: Contribution to journal › Review article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Chimeric Antigen Receptor–Engineered T Cell Therapy in Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences